MANGALAM DRUGS AND ORGANICS
Quarterly Results Analysis [Dec2023]
MANGALAM DRUGS AND ORGANICS Quarterly Results
Standalone | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹97 Cr | ₹82 Cr | ₹87 Cr | ₹91 Cr | ₹63 Cr | ₹108 Cr | ₹109 Cr | ₹121 Cr |
Expenses | ₹90 Cr | ₹79 Cr | ₹91 Cr | ₹91 Cr | ₹57 Cr | ₹100 Cr | ₹99 Cr | ₹111 Cr |
Operating Income | ₹7 Cr | ₹2 Cr | ₹-3 Cr | ₹0 Cr | ₹6 Cr | ₹8 Cr | ₹10 Cr | ₹10 Cr |
Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr |
Depreciation | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
Profit Before Tax | ₹0 Cr | ₹-5 Cr | ₹-10 Cr | ₹-6 Cr | ₹1 Cr | ₹3 Cr | ₹4 Cr | ₹5 Cr |
Profit After Tax | ₹1 Cr | ₹-4 Cr | ₹-10 Cr | ₹-4 Cr | ₹0 Cr | ₹2 Cr | ₹3 Cr | ₹7 Cr |
EPS | ₹0.32 | ₹-2.25 | ₹-6.02 | ₹-2.77 | ₹0.27 | ₹1.41 | ₹1.90 | ₹4.23 |
Industry Peers & Returns | 1W | 1M | 1Y |
MANGALAM DRUGS AND ORGANICS | -0.4% | -21.3% | -8.1% |
SUN PHARMACEUTICAL INDUSTRIES | 3% | 2.3% | 68.2% |
CIPLA | 2.5% | 0.4% | 71.7% |
DR REDDYS LABORATORIES | -0.2% | -4.9% | 40.3% |
ZYDUS LIFESCIENCES | 5% | 10.4% | 109.1% |
DIVIS LABORATORIES | -1.6% | -7% | 23.8% |
MANKIND PHARMA | NA | NA | NA |
TORRENT PHARMACEUTICALS | 2.9% | -2.2% | 69% |
LUPIN | 2.8% | 0% | 147.8% |
MANGALAM DRUGS AND ORGANICS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 19.35 % |
Y-o-Y | 53.70 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹97 Cr | 19.35 | |
Sep2023 | ₹82 Cr | -6.76 | |
Jun2023 | ₹87 Cr | -3.99 | |
Mar2023 | ₹91 Cr | 43.87 | |
Dec2022 | ₹63 Cr | -41.54 | |
Sep2022 | ₹108 Cr | -1.07 | |
Jun2022 | ₹109 Cr | -9.48 | |
Mar2022 | ₹121 Cr | - |
MANGALAM DRUGS AND ORGANICS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 218.10 % |
Y-o-Y | 7.84 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹7 Cr | 218.10 | |
Sep2023 | ₹2 Cr | Positive | |
Jun2023 | ₹-3 Cr | Negative | |
Mar2023 | ₹0 Cr | -96.26 | |
Dec2022 | ₹6 Cr | -23.29 | |
Sep2022 | ₹8 Cr | -18.73 | |
Jun2022 | ₹10 Cr | 1.75 | |
Mar2022 | ₹10 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 166.54 % |
Y-o-Y | -29.84 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 7.17% | 166.54 | |
Sep2023 | 2.69% | Positive | |
Jun2023 | -3.97% | Negative | |
Mar2023 | 0.27% | -97.36 | |
Dec2022 | 10.22% | 31.36 | |
Sep2022 | 7.78% | -17.93 | |
Jun2022 | 9.48% | 12.46 | |
Mar2022 | 8.43% | - |
MANGALAM DRUGS AND ORGANICS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | Positive |
Y-o-Y | 17.37 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹1 Cr | Positive | |
Sep2023 | ₹-4 Cr | Negative | |
Jun2023 | ₹-10 Cr | Negative | |
Mar2023 | ₹-4 Cr | Negative | |
Dec2022 | ₹0 Cr | -80.87 | |
Sep2022 | ₹2 Cr | -25.89 | |
Jun2022 | ₹3 Cr | -55.09 | |
Mar2022 | ₹7 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | Positive |
Y-o-Y | -23.88 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 0.51 % | Positive | |
Sep2023 | -4.36 % | Negative | |
Jun2023 | -10.9 % | Negative | |
Mar2023 | -4.81 % | Negative | |
Dec2022 | 0.67 % | -67.48 | |
Sep2022 | 2.06 % | -24.82 | |
Jun2022 | 2.74 % | -50.45 | |
Mar2022 | 5.53 % | - |
MANGALAM DRUGS AND ORGANICS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | Positive |
Y-o-Y | 18.52 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹0.32 | Positive | |
Sep2023 | ₹-2.25 | Negative | |
Jun2023 | ₹-6.02 | Negative | |
Mar2023 | ₹-2.77 | Negative | |
Dec2022 | ₹0.27 | -80.85 | |
Sep2022 | ₹1.41 | -25.79 | |
Jun2022 | ₹1.9 | -55.08 | |
Mar2022 | ₹4.23 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD